Replies to post #11184 on 22nd Century Group Inc (XXII)

[pharminvestor]

I believe Dupont and Syngenta are too big as an investee to allow XXII take 25% stake for 7ooK ie 2.8 million for the whole company. It makes sense that the investee is a small plant research company.
JMHO
GLTA

[macnqueso]

so xxii is buying a 25% stake in this entity for 700K... that does indicate that xxii management believes there is at least a 2.1 mil dollar value in the entity in addition to their own cash investment, that additional value may be intellectual property, cash or other tangible assets... and certainly the xxii management team would hope that whatever the current assets of this entity that the valuation of it would grow over time...

could there be some connection to Dupont... sure... but obviously this is not a deal made directly with Dupont proper... a separate entity has been established here... one with a tiny valuation of 2.8 mil... could Dupont have a presence in this entity just as XXII does... certainly... and that would indeed be exciting... whatever this tiny entity is, it's intellectual property appears to have caught the eye of xxii management...

perhaps the most important take away here is the very clear message it sends... while retail investors mostly speculate regarding MSA... xxii's management is busy building out a plant biotechnology company... they are many, many steps ahead of us... and quite proactive in their style as a management team...